Pharmacovigilance and Adverse Drug Reactions
Moving in medRxiv, bioRxiv, Gut and New England Journal of Medicine.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 5
Add Pharmacovigilance and Adverse Drug Reactions as an interest in JClubFree on iPhone and Android · interests shape Home, Discover and your digest
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Pharmacovigilance and Adverse Drug Reactions
Newest first · last 60 days
Lincosamides, penicillins, sulfonamides, and cephalosporins are linked to significantly increased CDI risk, with lincosamides showing the highest adjusted OR of 31.4 in the Swedish population.
- Open access
- 3 cites
Add Pharmacovigilance and Adverse Drug Reactions as an interest in JClub
Browse JClub
Journals this month
- bioRxiv6183
- medRxiv1716
- PNAS472
- Sci Adv398
- JAMA274
- Environ Res230
- BMJ200
- Nat Commun171
- Environ Pollution165
- Nature161
- NEJM146
- Science141
- Lancet132
- Cell Rep130
- Curr Biol108
- J Exp Bot108
- mBio107
- Plant Cell Environ107
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3